Real world outcomes for treatment of diffuse large B cell Lymphoma in patients aged 80 and over

被引：0
|
作者：
Cooke, R. [1 ]
Williams, C. [2 ]
Holmes, G. [2 ]
机构：
[1] Northumbria Healthcare NHS Trust, Newcastle Upon Tyne, Tyne & Wear, England
[2] Northumbria Healthcare NHS Trust, Haematol, Newcastle Upon Tyne, Tyne & Wear, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BSH2020-EP
引用
收藏
页码：233 / 234
页数：2
相关论文
共 50 条
  • [31] Treatment Outcomes with Standard of Care in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Real-World Data Analysis
    Ip, Andrew
    Mutebi, Alex
    Wang, Tongsheng
    Jun, Monika
    Kalsekar, Anupama
    Navarro, Fernando Rivas
    Wang, Anthony
    Kamalakar, Rajesh
    Sacchi, Mariana
    Elliott, Brian
    ADVANCES IN THERAPY, 2024, 41 (03) : 1226 - 1244
  • [32] GERIATRIC ASSESSMENT FOR THE ELDERLY PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) AND TREATMENT OUTCOMES
    Takamatsu, Y.
    Naito, Y.
    Sato, E.
    Ikari, Y.
    Katsuya, H.
    Goto, T.
    Shirahashi, A.
    Tanaka, T.
    Ishitsuka, K.
    Tamura, K.
    ANNALS OF ONCOLOGY, 2013, 24 : 53 - 53
  • [33] SURVIVAL STUDY IN PATIENTS AGED 80 AND OLDER WITH DIFFUSE LARGE B-CELL LYMPHOMA UNSPECIFIED SUBTYPE (NOS)
    Rumschisky Pablo, Palomo
    Moro Fernando, Martin
    Jarreta Lucia, Bolea
    Noguerales Blanca, De Felipe
    Palomanes Juan, Marquet
    Arribas Ana, Lario
    Cosio Monica, Garcia
    Juan Antonio, Garcia Vela
    Puente Pilar, Herrera
    Francisco Javier, Lopez Jimenez
    HAEMATOLOGICA, 2021, 106 (10) : 55 - 56
  • [34] Treatment of Diffuse Large B Cell Lymphoma
    Kwak, Jae-Yong
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2012, 27 (04): : 369 - 377
  • [35] Real-World Outcomes of Patients with Diffuse Large B-Cell Lymphoma Receiving Second Line Therapy in the United States
    Sawas, Ahmed
    Lau, Constance
    Thomson, Michael
    Maignan, Kathleen
    BLOOD, 2020, 136
  • [36] Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma: Real World Data
    Ferhanoglu, Burhan
    Gulbas, Zafer
    Uzay, Ant
    Ozcan, Muhit
    Ozkalemkas, Fahir
    Dal, Mehmet Sinan
    Kalyon, Hakan
    Akay, Olga Meltem
    Deveci, Burak
    Bekoz, Huseyin
    Sevindik, Omur Gokmen
    Toptas, Tayfur
    Yilmaz, Asu Fergun
    Koyun, Derya
    Alkis, Nihan
    Atesoglu, Elif Birtas
    BLOOD, 2022, 140 : 6704 - 6705
  • [37] Utilization of real-world data in assessing treatment effectiveness for diffuse large B-cell lymphoma
    Nowakowski, Grzegorz
    Maurer, Matthew J.
    Cerhan, James R.
    Dey, Debarshi
    Sehn, Laurie H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (01) : 180 - 192
  • [38] Tafasitamab for the treatment of patients with diffuse large B-cell lymphoma
    Pirosa, Maria Cristina
    Stathis, Anastasios
    Zucca, Emanuele
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [39] Treatment strategies for patients with diffuse large B-cell lymphoma
    Poletto, Stefano
    Novo, Mattia
    Paruzzo, Luca
    Frascione, Pio Manlio Mirko
    Vitolo, Umberto
    CANCER TREATMENT REVIEWS, 2022, 110
  • [40] Treatment of elderly patients with diffuse large B-cell lymphoma
    Nösslinger T.
    memo - Magazine of European Medical Oncology, 2016, 9 (1) : 8 - 12
12345